ICD 10 CM C69.4 | Description & Clinical Information

ICD 10 C69.4 describes a type of cancer that affects the ciliary body, which is a structure in the eye composed of ciliary muscles that are attached to the lens and release a transparent liquid called aqueous humor within the eye, and this malignant neoplasm is caused by various risk factors such as excessive sun exposure, light eye color, family history, and certain predisposing diseases like xeroderma pigmentosum and uveal nevus.

Official Description Of C69.4

The ICD 10 CM book defines ICD 10 code C69.4 as:

Malignant neoplasm of ciliary body
Parent Code Notes: C69

Excludes1: malignant neoplasm of connective tissue of eyelid (C49.0)
malignant neoplasm of eyelid (skin) (C43.1-, C44.1-)
malignant neoplasm of optic nerve (C72.3-)

When To Use C69.4

The diagnosis describes by the ICD-10-CM code C69.4 refers to a type of malignant neoplasm that affects the ciliary body, which is located in the eye. This specific diagnosis is known as melanoma of the ciliary body and it is known to develop from pigmented cells present in the eye. In early stages, patients may not manifest any symptoms, making the diagnosis of this type of cancer often challenging.

As the disease progresses, patients with melanoma of the ciliary body may experience severe eye pain, blurred vision, floaters or spots in their vision, and light sensitivity. Moreover, the cancer can spread to other tissues in the eye and invade other nearby structures. The symptoms vary depending on the stage of the disease, from being entirely asymptomatic in the early stages to become quite severe in the end-stage.

To diagnose the melanoma of the ciliary body, providers use a combination of different tools and techniques. Generally, doctors start by inquiring about the patient’s medical history, symptoms, and conducting a comprehensive eye exam, including dilation. They may also perform diagnostic tests such as an ultrasound examination of the eye, or magnetic resonance imaging (MRI) and computed tomography (CT) scans to assess how far the cancer has progressed and its exact location.

Another diagnostic tool used to diagnose melanoma of the ciliary body is a biopsy of the ocular lesion. This procedure involves taking a tissue sample from the suspicious lesion in the eye and examining it under the microscope. A biopsy can determine whether cancerous cells are present in the tissue and, if so, what type of cancer it is.

Once providers confirm the diagnosis of melanoma of the ciliary body, the next step is to implement the appropriate treatment plan. Treatment options depend on the stage of the cancer and the severity of the disease. Generally, if the cancer is resectable, surgical intervention is the primary course of action followed by chemotherapy and/or radiotherapy. The type of surgical treatment recommended may include enucleation, block excision, or other types of surgery.

Other available treatment options include brachytherapy and laser therapy. Brachytherapy involves placing a small radioactive plaque near the eye, while laser therapy involves the use of a high-energy laser beam to destroy cancerous tissue. These alternative treatments may be recommended for patients who are not good candidates for surgery or have a less advanced stage of the disease.

The prognosis for patients diagnosed with melanoma of the ciliary body depends on various factors, including the stage and extent of the cancer. Early detection is key for successful treatment and a better prognosis. However, the location of the tumor within the eye and its response to treatment also play vital roles in determining the outcome. Regular check-ups and follow-ups with an ophthalmologist are necessary for monitoring the condition’s progress and managing the treatment plan associated with this diagnosis code.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *